Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
166.6 USD | +1.59% | +25.36% | +67.53% |
07:00am | US, European nations consider vaccinating workers exposed to bird flu | RE |
05-24 | Novavax awaits FDA decision on whether its next COVID shot can be offered in US | RE |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+67.53% | 63.85B | |
-0.77% | 41.83B | |
+45.21% | 40.65B | |
-10.72% | 27.12B | |
+13.30% | 26.52B | |
-22.79% | 18.69B | |
+4.70% | 12.73B | |
+24.10% | 12.11B | |
+27.41% | 12.07B | |
-8.12% | 11.19B |
- Stock Market
- Equities
- MRNA Stock
- News Moderna, Inc.
- Transcript : Moderna, Inc. Presents at UBS Biopharma Conference 2023, Nov-09-2023 08